Back to news
Mitsui & Co. to build medical data network for clinical trials
ONE REPORT·Published ·Main source · Nikkei Asia
Story essentials
Mitsui & Co.
Asia
September 2026
Original reports
Mitsui & Co. is creating a medical data network across Asia.
The network aims to assist pharmaceutical companies in finding patients for clinical trials.
This page is produced by collecting and structuring multiple public reports. Sections based only on reporting or testimony affect the displayed assessment, and the page is updated when new information is identified.
About this article
COMPAMIR Editorial Team
The COMPAMIR editorial team brings together public reporting and links to the original coverage. We update the page as new information emerges.
Read our editorial policyRead next
Prioritized by shared people, places, and events.
Chugai Pharmaceutical researchers awarded Lasker-DeBakey Clinical Medical Research Award
Three Chugai researchers recognized for the invention of Hemlibra (emicizumab). Hemlibra is a bispecific antibody for hemophilia A treatment. Marks the second time Japanese researchers have received this award in the clinical category.